RAAB MICHAEL (CIK 1321402) reported 35 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-06-17). Recent activity: Buy ARDX (20,833 shares), Sell ARDX (41,666 shares), Sell ARDX (14,933 shares), Sell ARDX (7,861 shares), Sell ARDX (17,926 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-17 | ARDELYX, INC. (ARDX) | President & CEO | Buy | 20,833 | $20,625 |
| 2026-06-17 | ARDELYX, INC. (ARDX) | President & CEO | Sell | 41,666 | $236,346 |
| 2026-05-22 | ARDELYX, INC. (ARDX) | President & CEO | Sell | 14,933 | $93,593 |
| 2026-05-22 | ARDELYX, INC. (ARDX) | President & CEO | Sell | 7,861 | $49,269 |
| 2026-05-22 | ARDELYX, INC. (ARDX) | President & CEO | Sell | 17,926 | $112,351 |
| 2026-05-22 | ARDELYX, INC. (ARDX) | President & CEO | Sell | 14,028 | $87,920 |
| 2026-05-19 | ARDELYX, INC. (ARDX) | President & CEO | Buy | 20,833 | $20,625 |
| 2026-05-19 | ARDELYX, INC. (ARDX) | President & CEO | Sell | 41,666 | $261,612 |
| 2026-04-27 | AMICUS THERAPEUTICS, INC. (FOLD) | Director | Sell | 115,857 | $1.7M |
| 2026-04-17 | ARDELYX, INC. (ARDX) | President & CEO | Buy | 20,834 | $20,626 |
| 2026-04-17 | ARDELYX, INC. (ARDX) | President & CEO | Sell | 41,668 | $261,954 |
| 2026-03-18 | ARDELYX, INC. (ARDX) | President & CEO | Sell | 41,666 | $243,329 |
| 2026-03-18 | ARDELYX, INC. (ARDX) | President & CEO | Buy | 20,833 | $20,625 |
| 2026-02-25 | ARDELYX, INC. (ARDX) | President & CEO | Buy | 20,833 | $20,625 |
| 2026-02-25 | ARDELYX, INC. (ARDX) | President & CEO | Sell | 41,666 | $260,829 |
| 2026-02-23 | ARDELYX, INC. (ARDX) | President & CEO | Sell | 40,401 | $237,154 |
| 2026-02-23 | ARDELYX, INC. (ARDX) | President & CEO | Sell | 5,576 | $31,839 |
| 2026-02-23 | ARDELYX, INC. (ARDX) | President & CEO | Sell | 2 | $11 |
| 2026-02-23 | ARDELYX, INC. (ARDX) | President & CEO | Sell | 1 | $6 |
| 2026-02-23 | ARDELYX, INC. (ARDX) | President & CEO | Sell | 2 | $11 |
| 2026-01-26 | ARDELYX, INC. (ARDX) | President & CEO | Buy | 446,220 | $0 |
| 2025-11-25 | ARDELYX, INC. (ARDX) | President & CEO | Sell | 46,887 | $259,754 |
| 2025-08-25 | ARDELYX, INC. (ARDX) | President & CEO | Sell | 45,687 | $270,924 |
| 2025-06-06 | AMICUS THERAPEUTICS, INC. (FOLD) | Director | Buy | 20,414 | $0 |
| 2025-05-22 | ARDELYX, INC. (ARDX) | President & CEO | Sell | 46,817 | $191,013 |
Source: SEC Form 4 filings · as of 2026-06-17